Skip Sitewide NavigationHCFA logo: Return to home page 
 
 

Medicare Coverage Policy ~ Decisions

Noninvasive Positive Pressure RADs for COPD Patients (#CAG-00052)

Tracking Sheet


            
Issue HCFA is reviewing the use of (RAD) for severe chronic obstructive pulmonary disease (COPD) patients to determine if these devices for COPD patients meet the reasonable and necessary provision at section §1862(a)(1)(A) of the Medicare statute.
Background We have received inquiries from manufacturers, clinicians, and professional associations and groups, expressing concerns and requests for changes in the regional medical review policy (RMRP) for RAD used for category II patients with severe COPD. The National Association for Medical Directors of Respiratory Care hosted a multi-disciplinary consensus conference addressing specific applications for RAD in February 1998. The RMRP adopts all of the recommendations of the consensus conference, with exception of one. The recommendation not adopted concerns use of the device for severe chronic obstructive pulmonary disease (COPD) patients.

The RMRP for RAD is divided into four categories: (1.) restrictive thoraic disorders, e.g., neuromuscular disorders such as amyotrophic lateral sclerosis, (2.) severe chronic obstructive pulmonary disease (COPD), (3.) Central sleep apnea, i.e., apnea not due to airway obstruction, and (4.) obstructive sleep apnea (OSA). The RMRP for RAD used for COPD patients requires among other things, a facility-based polysonogram to rule out obstructive sleep apnea in order to initiate Medicare coverage, with a prerequisite trial of noninvasive ventilation without a backup rate and treatment with continuous positive airway pressure devices. We have been asked to review the RMRP for RAD for COPD patients and we will review entire RAD policy with the intent to make a national coverage decision.

Benefit Category §1861(n) Durable Medical Equipment
Requestor(s) Name HCFA Coverage and Analysis Group
Date of Request February 7, 2000
Current Due Date November 4, 2000
Lead Analyst(s) Francina C. Spencer
(410) 786-4614
Actions Taken
February 17, 2000 Intent to review current policy regarding use of RAD in COPD applications and if necessary develop a national coverage policy posted on HCFA website.
April 25, 2000 Met with representatives of the Coalition of Respiratory Care Manufacturers and the American Association for Homecare. They requested that the scope of this review be more narrowly defined to include "a small subgroup of very severely ill COPD patients, who require RAD with backup rate."
May 7, 2000 Due date revised. HCFA has extended its original date to August 7, 2000 to accomodate a requested change in focus of the review to a narrower subgroup of very severely ill COPD patients who require RAD with backup rate in the home setting and should not be subject to a trial on a RAD without backup. Requesters suggest this subgroup of patients are those who have recently been discharged from prolonged hospitalization during which RAD with backup rate was required for an extended period and now need to continue use of RAD in the home setting. While we are continuing to analyze this coverage issue, we are requesting evidence that supports the use of RAD devices for this subgroup of very severely ill COPD patients, identifies the population, and establishes the criteria to be used for this population of COPD patients when these devices are used in the home.
August 4, 2000 Received two articles as evidence to support use of the ventilator with backup rate for severely ill COPD patients during this period and revised due date for coverage decision to November 4, 2000, to adequately consider the evidence.


Medicare.gov | Department of Health and Human Services | NMEP

Home | Privacy Policy | Feedback | Help | Website Accessibility

FirstGov.gov